← Back to headlines
Eli Lilly Widens Lead Over Novo Nordisk in Obesity Drug Market
The gap between Eli Lilly and Novo Nordisk is expanding after their recent earnings reports, with Lilly strengthening its position in the obesity treatment race while Novo Nordisk works to regain market share.
6 Aug, 13:45 — 6 Aug, 13:45
Related Stories
Canada Announces Retaliatory Tariffs on US Goods Amid Escalating Trade Spat
4m ago
Canada Announces Retaliatory Tariffs on US Goods Amid Trade Dispute
20m ago
Canada just announced new tariffs on US goods. Here’s how the growing trade war could hurt Americans - CNN
32m ago
Dick's Sporting Goods Stock Plunges on Weak Outlook and Q2 Miss
35m ago